Repligen
RGEN
#1864
Rank
NZ$19.14 B
Marketcap
NZ$299.44
Share price
-3.81%
Change (1 day)
7.97%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2026 (TTM): NZ-$0.37

According to Repligen 's latest financial reports the company's current EPS (TTM) is NZ-$0.37. In 2025 the company made an earnings per share (EPS) of NZ$1.59 an increase over its 2024 EPS that were of NZ-$0.93.

EPS history for Repligen from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.37-123.47%
2025NZ$1.59-270.59%
2024NZ-$0.93-168%
2023NZ$1.37-77.68%
2022NZ$6.1443.59%
2021NZ$4.28105.26%
2020NZ$2.08153.33%
2019NZ$0.8218.42%
2018NZ$0.69-47.95%
2017NZ$1.33108.57%
2016NZ$0.6420.69%
2015NZ$0.5316%
2014NZ$0.46-48.98%
2013NZ$0.906.52%
2012NZ$0.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.30-455.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$34.71-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$15.96-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.26-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ-$0.69 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ-$2.78 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$12.74-3,585.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$2.14-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-55.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
NZ$1.86-610.00%๐Ÿ‡บ๐Ÿ‡ธ USA